Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A qualitative descriptive study to explore evaluation and effects of partnered rehabilitation research in Canada.

Health research policy and systems·2026

Same author

Youth's mental health journeys through the COVID-19 pandemic using arts-based methods in virtual environments.

PloS one·2026

Same author

Positive forces for care: understanding what drives HIV care uptake among African, Caribbean and Black women living with HIV in Winnipeg, Manitoba.

AIDS care·2026

Same author

An Umbrella Review of Relational Enablers of Psychological Safety and Identity-Related Gaps in the Evidence: Implications for Healthcare and Organizational Settings.

Journal of healthcare leadership·2026

Same author

Receipt of respite services among families of children and youth with special health care needs: A population-based cohort study.

International journal of population data science·2026

Same author

A Cluster Randomized Trial of an mHealth Intervention for Adolescents With Congenital Heart Disease: Rationale and Design of the READYorNot CHD Study.

CJC pediatric and congenital heart disease·2026

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Managing chronic hepatitis B in children.

Rhea J Mossman Sims¹, Roberta L Woodgate

¹University of Manitoba, Winnipeg, Manitoba, Canada. rp400b@mts.net

Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners

|October 31, 2008

Summary

Hepatitis B virus (HBV) affects children globally, posing treatment challenges. Pediatric nurse practitioners play a key role in managing chronic HBV in primary care settings, especially for immigrant and adopted children.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jun 28, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Area of Science:

Pediatric Healthcare
Hepatology
Infectious Diseases

Background:

Hepatitis B virus (HBV) infection is a persistent global health concern.
Managing chronic HBV in children presents significant treatment and care challenges.
HBV disproportionately affects immigrant and adopted children from endemic regions.

Purpose of the Study:

To outline the critical role of pediatric nurse practitioners (PNPs) in managing chronic HBV in children.
To highlight the primary care setting as a key location for HBV management.
To address the specific needs of immigrant and adopted children with chronic HBV.

Main Methods:

Literature review on HBV management in pediatric primary care.
Discussion of PNP responsibilities in diagnosis, treatment, and follow-up.
Analysis of challenges and strategies for managing chronic HBV in diverse pediatric populations.

Main Results:

PNPs are essential in identifying, monitoring, and managing chronic HBV in children.
Primary care provides a crucial setting for accessible HBV care and education.
Culturally sensitive approaches are vital for immigrant and adopted children.

Conclusions:

Pediatric nurse practitioners are integral to effective chronic hepatitis B management in primary care.
Early detection and consistent management are key to improving outcomes for children with HBV.
Addressing health disparities is crucial for controlling HBV in vulnerable pediatric populations.